Menu Back to 05

Track 5: Patient Engagement

DIA 2017: Driving Insights to Action

This track addresses meaningful patient engagement in medical product development, from early product development, and approval, through maintenance phases. It focuses on important questions for all stakeholders, including:

  • How do we meaningfully engage patients and incorporate their voices into decision-making throughout the medical product lifecycle?
  • How do we become truly patient- (and people-) centric in our approach?
  • How do we operationalize patient-centric approaches in our day-to-day work?
  • How can we measure the effectiveness of our efforts, both for patient outcomes and to meet the needs of other stakeholders such as industry and regulatory decision-makers?
  • What have we learned that can be used to drive more meaningful patient engagement?
  • How do stakeholders best work together to leverage their collective power and expertise to promote meaningful involvement of patients?

Sessions in Patient Engagement

Monday, June 28

Tuesday, June 29

Wednesday, June 30

Thursday, July 1

Who is This Track Designed For?

Professionals involved in: patient affairs, patient advocacy, patient groups, patient support services, medical affairs (including CMOs and MSLs), clinical trial design and optimization, clinical research and operations, regulatory affairs, regulatory agency, corporate and government affairs, safety and pharmacovigilance, outcomes research, epidemiology, and Health Technology Assessment..

View Other Tracks


Registration Rates

Back to DIA 2021

Back to DIAglobal.org